Alectinib ALK inhibitors

RO5424802 - alectinib - CH5424802      

pdf
pathology Demonstrated benefit and harm k      
lung cancer (metastatic)

versus chemotherapy

No demonstrated result for efficacy

1 trialmeta-analysis
lung cancer (metastatic)

versus crizotinib

alectinib superior to crizotinib in terms of PFS in ALEX, 2017 (1L patients)

1 trialmeta-analysis